Michael J. Thirman, C. Michel Zwaan, Neerav Shukla, Branko Cuglievan, Yu Gu, Rebecca G. Bagley, Kate Madigan, Yakov Chudnovsky, Huy Van Nguyen, Nicole McNeer, Andrew Wei, Shaun Fleming, Himalee Sabins, Ibrahim Aldoss, Tibor Kovacsovics, Richard Stone, Martha Arellano, Manish Patel, Chetasi Talati, Jing Chen, Boaz Nachmias, Maël Heiblig, Pau Montesios Fernandez, Montserrat Arnan-Sangerman, Eytan M. Stein, Ioannis Mantzaris, James S. Blachly, Elie Traer, C. Michael Zwaan, Ofir Wolach, Giovanni Marconi, Ashish Bajel, Carolyn S. Grove, Gabriel N. Mannis, Andre Schuh, Michael Thirman, John Byrd, Christine M. McMahon, David S. Dickens, Alexander Perl, Matthew Greenwood, Ghayas C. Issa, James Whitlock, Paul J. Shami, John DiPersio. "Menin Inhibition With Revumenib for
                    <i>KMT2A</i>
                    -Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101)." Journal of Clinical Oncology, 2025. doi:10.1200/jco.24.00826